A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lotfi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
Plans whose provider directory lists this clinician
Licensed to practise in California · since 2015 · expires 2028-08-31 · Royal College of Surgeons in Ireland Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$38,191
Medicare paid this office $38,191 for 175 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Largest Original Medicare bills
Return visit (30+ min)
97
$16,004
$102
Short return visit (20+ min)
80
$11,333
$75
New patient visit (60+ min)
41
$7,045
$172
Long return visit (40+ min)
19
$3,180
$151
Who their Medicare patients are
175 Original Medicare patients in 2024. Average age 70 · Women 73% · Also on Medicaid 15% · Health risk score 0.91. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
The office billed $141,888, Medicare allowed $53,813 and paid $38,191; for 377 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
Original Medicare by year
2024
175
377
70
0.91
$141,888
$38,191
2023
156
348
69
0.94
$138,476
$39,740
2022
158
335
67
1.07
$121,875
$36,320
2021
118
272
67
0.86
$100,879
$32,760
2020
92
271
68
1.25
$86,067
$26,540
2019
65
136
68
0.84
$51,590
$15,165
2018
168
601
75
1.23
$69,656
$19,719
2017
75
243
74
1.61
$35,756
$10,979
2015
137
268
71
2.91
$52,545
$22,042
2014
521
1,187
74
2.36
$241,912
$99,995
2013
193
409
74
1.99
$94,170
$37,819
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
Original Medicare services billed in 2023
Return visit (30+ min)
95
$14,956
$101
New patient visit (60+ min)
67
$12,603
$188
Short return visit (20+ min)
53
$8,940
$81
Long return visit (40+ min)
17
$2,670
$157
2022: 4 services
Original Medicare services billed in 2022
Return visit (30+ min)
89
$15,917
$104
New patient visit (60+ min)
44
$8,100
$184
Short return visit (20+ min)
62
$7,961
$80
Long return visit (40+ min)
22
$3,527
$147
2021: 5 services
Original Medicare services billed in 2021
Return visit (30+ min)
69
$16,320
$113
New patient visit (60+ min)
24
$5,066
$211
Long return visit (40+ min)
25
$4,448
$165
Short return visit (20+ min)
29
$3,488
$73
New patient visit (45+ min)
22
$3,182
$145
2020: 5 services
Original Medicare services billed in 2020
Return visit (30+ min)
56
$14,393
$97
New patient visit (45+ min)
19
$2,904
$153
Long return visit (40+ min)
18
$2,642
$132
Telephone medical discussion with physician, 21-30 minutes
18
$2,489
$104
Short return visit (20+ min)
21
$2,419
$59
2019: 3 services
Original Medicare services billed in 2019
Return visit (30+ min)
34
$6,685
$103
New patient visit (45+ min)
28
$3,980
$142
Long return visit (40+ min)
25
$3,067
$123
2018: 4 services
Original Medicare services billed in 2018
Return visit (30+ min)
96
$8,684
$90
Short return visit (20+ min)
43
$2,622
$61
New patient visit (30+ min)
11
$959
$87
Urinalysis, manual test
12
$41
$3
2017: 3 services
Original Medicare services billed in 2017
Return visit (30+ min)
54
$6,012
$99
New patient visit (45+ min)
14
$2,128
$152
Short return visit (20+ min)
13
$946
$68
2015: 4 services
Original Medicare services billed in 2015
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes
76
$9,841
$86
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
45
$3,891
$59
Hospital discharge day management, more than 30 minutes
35
$3,214
$89
Initial hospital care with moderate level of medical decision making at least 75 minutes
13
$2,166
$167
2014: 10 services
Original Medicare services billed in 2014
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes
267
$37,312
$85
Hospital discharge day management, more than 30 minutes
192
$17,136
$88
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
174
$16,309
$59
Initial hospital care with moderate level of medical decision making at least 75 minutes
73
$12,807
$166
Initial hospital observation care per day, typically 70 minutes
29
$4,405
$152
Hospital observation care on day of discharge
59
$3,532
$60
Follow-up observation care per day, typically 35 minutes
19
$1,632
$86
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes
13
$1,123
$32
Hospital discharge day management, 30 minutes or less
13
$780
$60
Follow-up observation care per day, typically 25 minutes
12
$774
$60
2013: 7 services
Original Medicare services billed in 2013
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes
95
$14,467
$83
Initial hospital care with moderate level of medical decision making at least 75 minutes
45
$7,277
$162
Hospital discharge day management, more than 30 minutes
64
$5,622
$86
Initial hospital observation care per day, typically 70 minutes
19
$2,805
$148
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
36
$2,639
$57
Extended inpatient or observation hospital service, first hour
11
$954
$73
Hospital observation care on day of discharge
16
$934
$58
Medicaid work
$26,028 in 2024
Medicaid paid $26,028 for 250 billed services this clinician did in 2024, up to 32 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
Largest Medicaid services in 2024
Return visit (30+ min)
250
$26,028
Medicaid work by year
2024
250
1
32
$26,028
2023
356
1
40
$29,691
2022
405
2
36
$28,999
2021
227
2
23
$17,343
2020
39
1
12
$2,303
See the largest Medicaid services in earlier years
2023
Largest Medicaid services in 2023
Return visit (30+ min)
356
$29,691
2022
Largest Medicaid services in 2022
Return visit (30+ min)
335
$25,595
Short return visit (20+ min)
70
$3,404
2021
Largest Medicaid services in 2021
Short return visit (20+ min)
122
$8,923
Return visit (30+ min)
105
$8,419
2020
Largest Medicaid services in 2020
Short return visit (20+ min)
39
$2,303
Drugs they prescribed that Part D paid
$486,579
Pharmacies billed $486,579 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 633) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
0 generic and 427 brand-name prescriptions · $486,579 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Ozempic
210
$248,648
$1,184
Mounjaro
132
$143,155
$1,085
Wegovy
28
$44,806
$1,600
Topiramate
39
$683
$18
Metformin Hcl Er
29
$372
$13
See all 10 drugs
Every Part D drug this clinician prescribed
Ozempic
210
$248,648
$1,184
Mounjaro
132
$143,155
$1,085
Wegovy
28
$44,806
$1,600
Topiramate
39
$683
$18
Metformin Hcl Er
29
$372
$13
Levoxyl
13
$315
$24
Levothyroxine
13
$195
$15
Ondansetron Odt
14
$170
$12
Metformin
12
$123
$10
Atorvastatin
15
$102
$7
Year by year
Part D prescribing by year
2024
633
102
0% (0)
67%
$486,579
2023
700
136
0% (0)
70%
$571,679
2022
399
81
0% (0)
56%
$248,882
2021
323
68
0% (0)
—None
$153,945
2020
229
42
0% (0)
42%
$84,479
2019
91
27
0% (0)
—None
$14,975
2018
173
82
—None
26%
$22,094
2017
61
28
0% (0)
—None
$10,255
2015
146
55
—None
—None
$7,093
2014
182
107
8% (14)
16%
$14,552
2013
98
45
—None
19%
$6,900
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
Part D drugs prescribed in 2023
Ozempic
346
$409,966
$1,185
Mounjaro
68
$78,347
$1,152
Trulicity
29
$30,619
$1,056
Topiramate
53
$1,745
$33
Metformin Hcl Er
39
$439
$11
Metformin
18
$401
$22
2022: 8 drugs
Part D drugs prescribed in 2022
Ozempic
117
$137,699
$1,177
Rybelsus
32
$48,062
$1,502
Jardiance
12
$18,668
$1,556
Trulicity
12
$11,269
$939
Mounjaro
11
$11,260
$1,024
Topiramate
69
$1,549
$22
Levoxyl
11
$119
$11
Metformin Hcl Er
23
$115
$5
2021: 6 drugs
Part D drugs prescribed in 2021
Ozempic
66
$67,875
$1,028
Rybelsus
23
$32,008
$1,392
Trulicity
15
$13,402
$893
Topiramate
79
$1,695
$21
Metformin Hcl Er
12
$137
$11
Vitamin D2
11
$59
$5
2020: 7 drugs
Part D drugs prescribed in 2020
Ozempic
20
$22,483
$1,124
Victoza 3-Pak
21
$21,381
$1,018
Jardiance
13
$11,000
$846
Topiramate
62
$1,425
$23
Bupropion Xl
13
$579
$45
Ultra-Fine Mini Pen Needle
13
$549
$42
Metformin Hcl Er
22
$256
$12
2019: 2 drugs
Part D drugs prescribed in 2019
Tradjenta
11
$4,520
$411
Topiramate
43
$498
$12
2018: 3 drugs
Part D drugs prescribed in 2018
Januvia
13
$7,351
$565
Repaglinide
11
$862
$78
Glipizide
21
$71
$3
2015: 2 drugs
Part D drugs prescribed in 2015
Topiramate
36
$404
$11
Metformin
16
$85
$5
2014: 3 drugs
Part D drugs prescribed in 2014
Prednisone
15
$108
$7
Levofloxacin
11
$58
$5
Furosemide
11
$46
$4
Money from drug and device companies
$217 in 2025
Industry payments by year
2025
1
2
—None
$217
2024
1
1
—None
$94
2022
1
1
—None
$30
2021
1
2
—None
$124
2019
1
3
—None
$235
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
Research payments by company and study
Novo Nordisk Inc · Heor-Palo Alto-Romanelli · 2022
Their institution
$146,920
Novo Nordisk AS · Heor-Palo Alto-Romanelli · 2021
Their institution
$70,452
Professional record
NPI
1619288685
Licence
CA A134702California A134702: Current · expires 2028-08-31